普萘洛尔联合奥美拉唑预防食管胃静脉曲张破裂再出血

中国临床药理学与治疗学 ›› 2008, Vol. 13 ›› Issue (6): 707-710.

普萘洛尔联合奥美拉唑预防食管胃静脉曲张破裂再出血

赖人旭, 郭惠学, 麦蕾

中山大学附属第五医院消化内科, 珠海 519000, 广东

收稿日期:2008-04-14 修回日期:2008-05-08 发布日期:2020-10-14
作者简介:赖人旭,男,博士,主治医师,研究方向:消化系病诊断和治疗。Tel:0756-2528841 E-mail:lairenxu@hotmail.com

Efficacy of propranolol combined with omeprazole in prevention of the patients with rebleeding caused by rupture of esophageal and gastric varices

LAI Ren-xu, GUO Hu-xue, MAI Lei

Department of Gastroenterology, the Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai 519000, Guangdong, China

Received:2008-04-14 Revised:2008-05-08 Published:2020-10-14

摘要/Abstract

摘要： 目的: 探讨联合普萘洛尔和奥美拉唑维持治疗对预防食管胃静脉曲张破裂再出血的疗效。方法: 85例肝硬化门脉高压患者随机分为2组:Ⅰ组42例:普萘洛尔,Ⅱ组43例:联合普萘洛尔和奥美拉唑。维持治疗6个月并随访1年。观察治疗后2组患者食管胃静脉曲张程度、出血的复发率及胃黏膜的改善情况。结果: Ⅰ组和Ⅱ组食管胃静脉曲张加重程度无显著性变化(P>0.05);2组再出血的复发率分别为35.0%和15.0%,Ⅱ组显著低于Ⅰ组(P<0.05);内镜下胃黏膜恢复总有效率Ⅱ组为92.5%,Ⅰ组为60.0%,两组差异有统计学意义(P<0.01)。结论: 普萘洛尔联合奥美拉唑维持治疗可有效预防食管胃静脉曲张破裂再出血。

关键词: 普萘洛尔, 奥美拉唑, 食管静脉曲张, 胃静脉曲张, 出血预防

Abstract: AIM: To study the efficacy of propranolol combined with omeprazole with maintenance therapy in prevention of the patients with rebleeding caused by rupture of esophageal and gastric varices.METHODS: 85 cases patients with hepatocirrhosis portal hypertension were divided into two groups randomly: group Ⅰ (propranolol, n=42) and group Ⅱ (propranolol plus omeprazole, n=43).The duration of maintenance therapy was six months, and followed up one year.The aggravation of esophageal and gastric varices, recurrence rates of hemorrhage and the lesions of gastric mucosa were examined and evaluated by gastroendoscopy before and after the period of treatment.RESULTS: After one year's observation, the aggravation of esophageal and gastric varices among two groups had not significant difference (P>0.05);the annual recurrence rates of hemorrhage of group Ⅰ and group Ⅱ were 35.0% and 15.0% respectively, the recurrence rates of hemorrhage in group Ⅱ was significantly lower than that of group Ⅰ (P<0.05), The total effective rates in improving gastric mucosa was 92.5% in group Ⅱ, while 60.0% in group Ⅰ,which was significantly lower than that of group Ⅱ(P<0.01).CONCLUSION: The effect of propranolol plus omeprazole in prevention of the patients with rebleeding caused by rupture of esophageal and gastric varices is effective.

Key words: propranolol, omeprazole, esophageal varices, gastric varices, hemorrhage prevention

中图分类号:

R571

赖人旭, 郭惠学, 麦蕾. 普萘洛尔联合奥美拉唑预防食管胃静脉曲张破裂再出血[J]. 中国临床药理学与治疗学, 2008, 13(6): 707-710.

LAI Ren-xu, GUO Hu-xue, MAI Lei. Efficacy of propranolol combined with omeprazole in prevention of the patients with rebleeding caused by rupture of esophageal and gastric varices[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(6): 707-710.

参考文献

[1] 中华内科杂志编辑部. 食管胃静脉曲张出血的诊治建议(草案)[J]. 中华内科杂志, 2006, 45(6): 524-526.
[2] 中华消化内镜学会. 食管胃底静脉曲张内镜下诊断和治疗规范试行方案[J]. 中华消化内镜杂志, 2000, 17(4): 198-199.
[3] 李新华, 张万岱, 张振书. 门静脉高压性胃病研究现状[J]. 中华消化内镜杂志, 2003, 20(2): 140-142.
[4] Dursun M, Yilmaz S, Yukselen V, et al. Analysis of 1242 cases with upper gastrointestinal system bleeding in South eastern Turkey: a different etiologic spectrum[J]. Hepatogastroenterology, 2005, 52(65): 1456-1458.
[5] 钟利春, 贾红, 李昌平, 等. 套扎与硬化剂比较治疗肝硬化食管静脉曲张出血的中文随机试验的系统评价[J]. 中国循证医学杂志, 2007, 7(2): 135-141.
[6] Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial[J]. Hepatology, 2000, 32(3): 461-465.
[7] Hou MC, Lin HC, Lee FY, et al. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation[J]. J Hepatology, 2000, 32(2): 202-208.
[8] 北京地区食管胃静脉曲张出血调查协作组. 北京地区门脉高压食管胃静脉曲张出血调查分析[J]. 中华消化杂志, 2002, 22(3): 160-163.
[9] Groszmann RJ, Garcia Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis[J]. N Engl JMed, 2005, 353(21): 2254-2261.
[10] Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J]. Hepatology, 2007, 46(3): 922-938.
[11] Bureau C, Peron JM, Alric L, et al. “A La Carte” treatment of portal hypertension:Adapting medical therapy to hemodynamic response for the prevention of bleeding[J]. Hepatology, 2002, 36(6): 1361-1366.
[12] 桑山肇. 食道静瘤再出血と酸分泌抑制[J]. e-CLINICIAN, 2006, 547(53): 101-107.